These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 19464093)

  • 1. Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease.
    Frasch CE; Borrow R; Donnelly J
    Vaccine; 2009 Jun; 27 Suppl 2():B112-6. PubMed ID: 19464093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal surrogates of protection--serum bactericidal antibody activity.
    Borrow R; Balmer P; Miller E
    Vaccine; 2005 Mar; 23(17-18):2222-7. PubMed ID: 15755600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal antibody assays - The role of complement in infection and immunity.
    McIntosh ED; Bröker M; Wassil J; Welsch JA; Borrow R
    Vaccine; 2015 Aug; 33(36):4414-21. PubMed ID: 26187262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.
    Lucidarme J; Louth J; Townsend-Payne K; Borrow R
    Methods Mol Biol; 2019; 1969():169-179. PubMed ID: 30877677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring antigen-specific bactericidal responses to a multicomponent vaccine against serogroup B meningococcus.
    Giuliani MM; Biolchi A; Serruto D; Ferlicca F; Vienken K; Oster P; Rappuoli R; Pizza M; Donnelly J
    Vaccine; 2010 Jul; 28(31):5023-30. PubMed ID: 20493284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.
    Granoff DM
    Vaccine; 2009 Jun; 27 Suppl 2(Suppl 2):B117-25. PubMed ID: 19477054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.
    Welsch JA; Moe GR; Rossi R; Adu-Bobie J; Rappuoli R; Granoff DM
    J Infect Dis; 2003 Dec; 188(11):1730-40. PubMed ID: 14639545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.
    Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ
    Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of steroid-treated former preterm infants to a single dose of meningococcal C conjugate vaccine.
    Clarke P; Robinson MJ; Ahmad I; Bedford-Russell AR; Connell JE; Powell PJ; Heath PT
    Vaccine; 2006 Apr; 24(16):3273-8. PubMed ID: 16472548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.
    Abad R; Biolchi A; Moschioni M; Giuliani MM; Pizza M; Vázquez JA
    Clin Vaccine Immunol; 2015 Apr; 22(4):357-60. PubMed ID: 25630407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
    Borrow R; Goldblatt D; Andrews N; Richmond P; Southern J; Miller E
    J Infect Dis; 2001 Aug; 184(3):377-80. PubMed ID: 11443568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.
    Su EL; Snape MD
    Expert Rev Vaccines; 2011 May; 10(5):575-88. PubMed ID: 21604979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.
    Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM
    Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
    Plested JS; Welsch JA; Granoff DM
    Clin Vaccine Immunol; 2009 Jun; 16(6):785-91. PubMed ID: 19339487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vaccine potential of the Neisseria-specific protein NMB0938.
    Sardiñas G; Climent Y; Rodríguez Y; González S; García D; Cobas K; Caballero E; Pérez Y; Brookes C; Taylor S; Gorringe A; Delgado M; Pajón R; Yero D
    Vaccine; 2009 Nov; 27(49):6910-7. PubMed ID: 19751688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac.
    Caron F; Delbos V; Houivet E; Deghmane AE; Leroy JP; Hong E; Bénichou J; Taha MK
    Vaccine; 2012 Jul; 30(34):5059-62. PubMed ID: 22658929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.